Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
gene therapy
harvard pilgrim health care
life sciences
luxturna
2
×
national blog main
national top stories
new york blog main
spark therapeutics
achromatopsia
alnylam pharmaceuticals
amy schulman
andreas klein
anna greka
barry greene
beta-thalassemia
bill cassidy
bluebird bio
boston
car-t
caron jacobson
cigall kadoch
clinical trials
craig mello
dan ollendorf
deals
dna
events
fda
foghorn therapeutics
goldfinch biopharma
hemophilia
institute for clinical and economic review
johnson & johnson
mark warner
mathai mammen
medicaid
meiragtx
michael sherman
What
gene
therapy
2
×
age
aren’t
bigger
biggest
car
come
cutting
deal
edge
emerging
experiments
gave
hot
interference
j
johnson
launch
market
medicines
meiragtx
morning
past
payers
photos
real
rna
science
signal
signals
soon
they’re
t’s
vs
what’s
years
Language
Current search:
luxturna
×
therapy
×
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”
